Finance

Lists
Q2 2026 earnings • released • EPS beat +24.33% • Revenue beat +1.76%
See results
CNMD:NYSE
Conmed Corp
$46.30
-1.45%
(-0.68) 1D
Jul 31, 4:00:02 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CNMD...
Open
$45.60
High
$46.78
Low
$45.24
Mkt. cap
1.39B
Avg. vol.
772.59K
Volume
20.00
P/E ratio
25.07
52-wk high
$56.64
52-wk low
$31.44
EPS
$1.85
Beta
0.93
Shares outstanding
29.95M
No. of employees
4K
Open
$45.60
High
$46.78
Low
$45.24
Mkt. cap
1.39B
Avg. vol.
772.59K
Volume
20.00
P/E ratio
25.07
52-wk high
$56.64
52-wk low
$31.44
EPS
$1.85
Beta
0.93
Shares outstanding
29.95M
No. of employees
4K
News stories
From sources across the web
About Conmed Corp
CEOCurt R. Hartman
Employees3.9K
Founded1970
HeadquartersLargo, Florida, United States
SectorMedical device
Websiteconmed.com
Analyst ratings
Based on 6 analysts giving stock ratings to CNMD in the past 3 months
Hold
Buy
0
Hold
5
Sell
1
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for CNMD in the last 3 months.
Highest
Current $46.30
$46.00 (-0.65%)
Average
$45.25 (-2.27%)
Lowest
$45.00 (-2.81%)
Analyst
Recommendation
Action
Price target
Projected
Date
Travis Steed
Bank of America Securities
Sell
Maintained
-
-
07/30/2026
Robbie Marcus
J.P. Morgan
Hold
Reiterated
$45.00
-2.8%
07/30/2026
Vik Chopra
BMO Capital
Hold
Maintained
$45.00
-2.8%
07/29/2026
Larry Biegelsen
Wells Fargo
Hold
Maintained
$46.00
-0.6%
07/30/2026
Matthew O'Brien
Piper Sandler
Hold
Reiterated
$45.00
-2.8%
07/30/2026
Michael Matson
Needham
Hold
Maintained
-
-
07/30/2026
Unknown Analyst
BMO Capital
Hold
Initiated
$36.00
-22.2%
07/09/2026
Last report
Jul 29, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
$1.38 / $1.11
+24.33%beat
Revenue / Est. (USD)
343.49M / 337.54M
+1.76%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
337.93M
373.20M
317.05M
343.49M
Cost of goods sold
148.41M
196.81M
133.60M
139.13M
Cost of revenue
148.41M
196.81M
133.60M
139.13M
Research and development expenses
13.90M
14.90M
16.33M
15.50M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
139.00M
134.42M
133.48M
138.57M
Operating expense
152.90M
149.31M
149.81M
154.07M
Total operating expenses
301.31M
346.13M
283.41M
293.20M
Operating income
36.62M
27.07M
33.64M
50.29M
Other non operating income
-
-363.00K
-
2.82M
EBT including unusual items
4.27M
29.25M
18.36M
31.35M
EBT excluding unusual items
29.01M
19.34M
26.58M
45.23M
Income tax expense
1.41M
12.51M
4.53M
8.28M
Effective tax rate
33.09%
42.78%
24.66%
26.40%
Other operating expenses
-
-
-
-
Net income
2.86M
16.74M
13.83M
23.07M
Net profit margin
0.85%
4.49%
4.36%
6.72%
Earnings per share
1.08
1.43
0.89
1.38
Interest and investment income
-
-
-
-
Interest expense
-7.61M
-7.37M
-7.06M
-7.88M
Net interest expenses
-7.61M
-7.37M
-7.06M
-7.88M
Depreciation and amortization charges
-
-
-
-
EBITDA
55.23M
44.72M
52.47M
69.34M
Gain or loss from assets sale
-
-
-3.92M
2.40M
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps